394 related articles for article (PubMed ID: 16139580)
1. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Rush AJ; Marangell LB; Sackeim HA; George MS; Brannan SK; Davis SM; Howland R; Kling MA; Rittberg BR; Burke WJ; Rapaport MH; Zajecka J; Nierenberg AA; Husain MM; Ginsberg D; Cooke RG
Biol Psychiatry; 2005 Sep; 58(5):347-54. PubMed ID: 16139580
[TBL] [Abstract][Full Text] [Related]
2. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
Rush AJ; Sackeim HA; Marangell LB; George MS; Brannan SK; Davis SM; Lavori P; Howland R; Kling MA; Rittberg B; Carpenter L; Ninan P; Moreno F; Schwartz T; Conway C; Burke M; Barry JJ
Biol Psychiatry; 2005 Sep; 58(5):355-63. PubMed ID: 16139581
[TBL] [Abstract][Full Text] [Related]
3. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
George MS; Rush AJ; Marangell LB; Sackeim HA; Brannan SK; Davis SM; Howland R; Kling MA; Moreno F; Rittberg B; Dunner D; Schwartz T; Carpenter L; Burke M; Ninan P; Goodnick P
Biol Psychiatry; 2005 Sep; 58(5):364-73. PubMed ID: 16139582
[TBL] [Abstract][Full Text] [Related]
4. Vagus nerve stimulation for depression: efficacy and safety in a European study.
Schlaepfer TE; Frick C; Zobel A; Maier W; Heuser I; Bajbouj M; O'Keane V; Corcoran C; Adolfsson R; Trimble M; Rau H; Hoff HJ; Padberg F; Müller-Siecheneder F; Audenaert K; Van den Abbeele D; Stanga Z; Hasdemir M
Psychol Med; 2008 May; 38(5):651-61. PubMed ID: 18177525
[TBL] [Abstract][Full Text] [Related]
5. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
6. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.
Sackeim HA; Rush AJ; George MS; Marangell LB; Husain MM; Nahas Z; Johnson CR; Seidman S; Giller C; Haines S; Simpson RK; Goodman RR
Neuropsychopharmacology; 2001 Nov; 25(5):713-28. PubMed ID: 11682255
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
Cristancho P; Cristancho MA; Baltuch GH; Thase ME; O'Reardon JP
J Clin Psychiatry; 2011 Oct; 72(10):1376-82. PubMed ID: 21295002
[TBL] [Abstract][Full Text] [Related]
8. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.
Rush AJ; Siefert SE
Exp Neurol; 2009 Sep; 219(1):36-43. PubMed ID: 19397908
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
Burke MJ; Husain MM
J ECT; 2006 Sep; 22(3):218-22. PubMed ID: 16957540
[TBL] [Abstract][Full Text] [Related]
11. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression.
Loo CK; Mitchell PB; McFarquhar TF; Malhi GS; Sachdev PS
Psychol Med; 2007 Mar; 37(3):341-9. PubMed ID: 17176505
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
13. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.
Rossini D; Lucca A; Zanardi R; Magri L; Smeraldi E
Psychiatry Res; 2005 Nov; 137(1-2):1-10. PubMed ID: 16225930
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
[TBL] [Abstract][Full Text] [Related]
15. Combined VNS-rTMS treatment in a patient with therapy resistant depression.
Sperling W; Kornhuber J; Wiltfang J; Bleich S
Pharmacopsychiatry; 2007 Jan; 40(1):39-40. PubMed ID: 17327961
[No Abstract] [Full Text] [Related]
16. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
17. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
Nierenberg AA; Alpert JE; Gardner-Schuster EE; Seay S; Mischoulon D
Biol Psychiatry; 2008 Sep; 64(6):455-60. PubMed ID: 18571625
[TBL] [Abstract][Full Text] [Related]
18. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.
Neuhaus AH; Luborzewski A; Rentzsch J; Brakemeier EL; Opgen-Rhein C; Gallinat J; Bajbouj M
J Affect Disord; 2007 Jun; 100(1-3):123-8. PubMed ID: 17098290
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
